Trial search - ClinicalTrials.eu

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

Study of Sacituzumab Govitecan, Zimberelimab, and Domvanalimab for Patients with Muscle Invasive Bladder Cancer Ineligible for Cisplatin Chemotherapy

Not recruiting

1 1 1
Investigated diseases:
- Bladder cancer
Investigated drugs:
Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

Not recruiting

1 1 1
Investigated diseases:
Investigated drugs:
- Nivolumab
- Relatlimab
+3
Study on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Bladder cancer
Investigated drugs:
+2
Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

Not recruiting

1 1 1 1
Investigated diseases:
- Bladder cancer
Investigated drugs:
- Gemcitabine Hydrochloride
- Mitomycin
+1
Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Bladder cancer
Investigated drugs:
+5
Study on Atezolizumab with Radiotherapy for Patients with Muscle-Invasive Bladder Cancer

Not recruiting

1 1 1
Investigated diseases:
- Bladder cancer
Investigated drugs:
- Atezolizumab
Study of Sasanlimab with BCG or Alone for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Not Responding to BCG

Not recruiting

1 1 1
Investigated drugs:
- Sasanlimab
Study on the Effectiveness of Durvalumab, Tremelimumab, and Chemotherapy in Patients with Advanced Bladder or Urinary System Cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Bladder cancer
Investigated drugs:
Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

Not recruiting

1 1 1 1
Investigated drugs:
+3
Study on BI 907828 for Patients with Advanced Biliary Tract, Pancreatic, Lung, or Bladder Cancer

Not recruiting

1 1
Investigated diseases:
Investigated drugs:
- (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid

Find clinical trials in your area

Matched clinical trials

We use cookies